Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.

Prochaska J, Rubinstein M, Perdok R, Blumenstein B, Jacobs C

Open source

DOI
10.1136/thorax-2025-223880
Published
2026 Jan 15
Container
Thorax
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/thorax-2025-223880,
  title = {Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.},
  author = {Prochaska J and Rubinstein M and Perdok R and Blumenstein B and Jacobs C},
  year = {2026},
  journal = {Thorax},
  doi = {10.1136/thorax-2025-223880},
  url = {https://doi.org/10.1136/thorax-2025-223880}
}

RIS

TY  - JOUR
TI  - Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
AU  - Prochaska J
AU  - Rubinstein M
AU  - Perdok R
AU  - Blumenstein B
AU  - Jacobs C
PY  - 2026
JO  - Thorax
DO  - 10.1136/thorax-2025-223880
UR  - https://doi.org/10.1136/thorax-2025-223880
ER  - 

APA

J, P., M, R., R, P., B, B., & C, J. (2026). Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.. Thorax. https://doi.org/10.1136/thorax-2025-223880

Source records